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DNA damage checkpoints are essential for maintenance of genome integrity. We report here that
inducible overexpression of the transcription factor Sharp-1 results in an S and G2/M cell cycle
arrest, concomitant with the upregulation of Brca1 and GADD45a expression. In addition, we show
that endogenous Sharp-1 mRNA is increased by DNA-damaging agents. Consistently, Sharp-1 over-
expressing cells exhibit reduced apoptosis in response to chemotherapeutic drugs along with lower
p53 expression and activity. Our studies identify a novel function for Sharp-1 in cell cycle arrest and
DNA damage-induced apoptosis. Inappropriate Sharp-1 expression may therefore be associated with
tumorigenesis.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Genome integrity is dependent on the activation of check-
points that block cell cycle progression [1–5]. In response to cel-
lular stress such as DNA damage, mammalian cells arrest in the
G1, S, or G2/M phase that allows them to repair DNA. The G2
checkpoint plays a pivotal role in this process by inhibiting
the entry of cells harboring DNA damage into mitosis. If the
damage cannot be repaired, programmed cell death (apoptosis)
is initiated to eliminate genetically altered cells from the prolif-
erative pool. The tumor suppressor p53 plays a key role in the
DNA-damage response. In addition to its established role in G1
arrest through regulation of p21cip1/waf1 expression, p53 plays a
role in G2/M arrest through regulation of GADD45a, 14-3-3,
and cyclin B1 [5]. p53 also regulates the expression of genes re-
quired for apoptosis which include Puma, Noxa and Bax [6,7]. A
failure of this surveillance response results in genetic alterations
that lead to genome instability and development of cancers,
immunodeﬁciency, neurodegenerative diseases, and premature
ageing [1–5].
We have previously demonstrated that the transcription fac-
tor Sharp-1/Dec2 is widely expressed, and plays key roles in
cellular differentiation [8–10]. The hitherto unstudied role of
Sharp-1 in regulation of cellular growth arrest and apoptosischemical Societies. Published by E
ysiology, National University
117597, Singapore. Fax: +65are addressed in this present report. We demonstrate that
endogenous Sharp-1 mRNA is up-regulated by genotoxic agents,
and its overexpression results in S and G2/M cell cycle arrest.
Sharp-1 upregulates the expression of Brca1 and GADD45a, that
control cell cycle arrest and DNA repair [11,12]. Consistent with
its ability to block cell cycle progression, Sharp-1 overexpress-
ing cells exhibit an abrogated apoptotic response in presence
of DNA damaging triggers and express reduced levels of p53
and its transcriptional targets. Together, our studies demon-
strate that Sharp-1 plays a key role in protection of cells from
anti-cancer drugs, and suggest that its altered function or
expression may be associated with tumorigenesis and or tumor
progression.2. Materials and methods
2.1. Cell culture
Doxycycline inducible Sharp-1 expressing cell lines were
generated using the rtTA inducible system. NIH3T3 ﬁbroblast
cells (ATCC) were transfected with EF1prtTA [13] and selected
with G418. After selection, cells were co-transfected with
myc-tagged Sharp-1 in pUHD10-3 and a puromycin resistance
vector [14]. Individual colonies were analyzed for Sharp-1
expression in response to doxycycline (2 lg/ml). Cells contain-
ing both vectors but not induced with doxycycline were used
as controls. Cells were cultured in DMEM supplemented with
10% bovine serum.lsevier B.V. All rights reserved.
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Colony formation assays were done as described [14]. Colonies
were stained with crystal violet. The dye was extracted and the
absorbance read at 570 nm.Fig. 1. Sharp-1 causes cell cycle arrest. (A) Sharp-1 expression was induced with doxycyc
used as a loading control. Cells were immunostained 24 h after doxycline treatment and
(B) Cells were plated in triplicates at a density of 0.1  106 and left untreated (control)
counted by trypan blue assay. Error bars indicate mean ± standard error (S.E.). (C) NIH3
10 days, and colonies were stained with crystal violet. The panel on the left shows repres
extracted and the absorbance read at 570 nm (right). Sharp-1 expressing cells showed a
with doxycycline (24 h) were analyzed by FACS. The left panel shows representativ
overexpression. Quantiﬁcation (right panel) of the percentage cells undergoing S and G2
controls (*P < 0.05). Results are means ± S.E. from four independent experiments.2.3. Cell cycle analysis
Cell cycle analysis was done as described [14]. Flow cytometry
was performed in a BD Coulter ﬂow cytometer and analyzed using
WINMDI software.line for 0–72 h and analyzed by Western blot using anti-myc antibody. GAPDH was
analyzed by ﬂuorescence microscopy. Nuclei were stained with DAPI (lower panel).
or treated with doxycycline (Sharp-1). Twenty-four hours later, cell numbers were
T3 cells without or with doxycycline treatment were cultured at a low density for
entative plates from two independent experiments. For quantiﬁcation, the dye was
signiﬁcant reduction in colony formation (*P < 0.05). (D) Control and cells treated
e histograms of cell cycle proﬁles in cells without (control) and with Sharp-1
arrest indicated a signiﬁcant increase in Sharp-1 overexpressing cells compared to
J.-J. Liu et al. / FEBS Letters 584 (2010) 619–624 6212.4. Caspase-3 activity
Caspase-3 activity assays were based on cleavage of the sub-
strate Ac-DEVD-pNA [Biomol International]. Cleavage of the sub-
strate was measured spectrophotometrically at 405 nm and the
activity calculated.
2.5. Reverse transcriptase PCR (RT-PCR)
Semi-quantitative, and quantitative RT-PCR was done as
described [10,15]. Primers sequences are listed in Supplementary
Table 1.
2.6. Statistical analysis
Error bars indicate means ± standard error (S.E.). Statistical
analysis was performed by Student’s t-test and P values < 0.05 were
considered statistically signiﬁcant.
3. Results and discussion
3.1. Sharp-1 causes growth arrest
To investigate the role of Sharp-1 in growth arrest and apopto-
sis, we established stable cell lines in NIH3T3 cells that express
myc-tagged Sharp-1 in a doxycycline inducible manner. Cells con-
taining the Sharp-1 construct, but not induced with doxycycline,
were used as controls. To examine the kinetics of Sharp-1 induc-
tion, cells were left untreated (time 0) or treated with doxycy-
cline for various time points and analyzed by Western blot
analysis. In the absence of doxycycline, Sharp-1 expression was
not detectable using anti-myc antibody (Fig. 1A, time 0 h). Treat-
ment of cells with doxycycline resulted in the induction of Sharp-
1 within 8 h, which was apparent until 72 h (Fig. 1A). Immunoﬂu-
orescence analysis indicated that Sharp-1 was localized in the nu-
cleus (Fig. 1A, lower panel). Compared to control cells, the
induction of Sharp-1 expression resulted in a signiﬁcant reduction
of cell numbers (Fig. 1B). To conﬁrm the growth inhibitory effect
of Sharp-1, colony formation assays were performed. NIH3T3 cells
were cultured in the absence or presence of doxycycline and col-
ony formation was visualized by crystal violet staining (Fig. 1C,
left panel). Sharp-1 expression resulted signiﬁcant decrease in
colony numbers compared to control cells (Fig. 1C, right panel).
Together, these results demonstrate that Sharp-1 is a potent
growth suppressor. To investigate whether Sharp-1 mediated
growth suppression is due to an effect on the cell cycle, or on
apoptosis, we ﬁrst performed cell cycle analysis (Fig. 1D). Inter-
estingly, 24 h after induction of Sharp-1, a signiﬁcant increase
in the percentage of cells in the S and G2/M phases was evident,
with no obvious increase in the sub-G1 population (Fig. 1D, left
panel).
We then analyzed the mechanisms underlying growth arrest
induced by Sharp-1. The G2/M checkpoint is controlled by the
cyclin B/Cdc2 complex. Compared to control cells, cyclin B1
expression was somewhat increased after induction of Sharp-1,
whereas the levels of p-cdc2-Tyr15, which inhibits cyclin B/
Cdc2 activity [16] remained unchanged (Fig. 2A). Moreover, no
changes in the levels of p21 and Cdk2 were apparent. However,
p53 levels were increased 36 h after Sharp-1 expression com-
pared to control cells. One of the key p53 target genes involved
in G2/M arrest is GADD45a [11]. In control cells, GADD45a was
slightly increased over time. Interestingly, GADD45a mRNA was
up-regulated by Sharp-1 even prior to the induction of p53, indi-
cating that GADD45a may be directly regulated by Sharp-1
(Fig. 2B). Similarly, Brca1, which is required for S-phase arrestand DNA-repair was induced by Sharp-1 (Fig. 2B). A hallmark
of entry into mitosis is the phosphorylation of histone H3 [17].
In control cells, histone H3 phosphorylation (ser 10) was in-
creased at 16 h (Fig. 2C). In contrast, Sharp-1 overexpressing cells
showed a marked reduction in phospho H3 levels conﬁrming
that Sharp-1 disrupts G2 progression. Given the S-phase arrest
induced by Sharp-1, we further examined genes involved in
DNA-replication or repair [1–5,12]. However, the expression of
RPA, 53BP1, MDC1 and PCNA was not altered by Sharp-1 overex-
pression (Fig. 2D and E).
3.2. Sharp-1 is induced by genotoxic agents and protects cells from
apoptosis
The DNA-damage pathway activates the G2/M checkpoint,
which provides a survival mechanism in mammalian cells [18].
Since Sharp-1 expression results in a pronounced G2/M arrest,
we investigated its role in the DNA-damage response. We ﬁrst ana-
lyzed whether Sharp-1 expression is modulated by DNA damage.
NIH3T3 cells were treated with the anti-cancer drugs 5-FU, cis-
platin, and etoposide (Fig. 3A and B). Interestingly, similar to GAD-
D45a, Sharp-1 mRNA was elevated by all genotoxic stimuli
(Fig. 3A, left panel and B) suggesting that it may modulate the cel-
lular response to chemotherapeutic drugs. Sharp-1 expression
however, was not increased by prolonged culture in the absence
of drug treatment (Fig. 3A, right panel).
Since Sharp-1 is up-regulated by genotoxic agents and triggers
arrest, we hypothesized that Sharp-1 expression may favor cell
survival in face of DNA damage. We therefore examined the effect
of Sharp-1 on DNA-damage-induced apoptosis. Sharp-1 was in-
duced with doxycycline for 8 h, and cells were then treated with
5-FU or cisplatin. The extent of apoptosis was assayed by ﬂow
cytometry using the sub-G1 fraction as a surrogate marker. In con-
trol cells treated with 12.5 lM or 25 lM 5-FU alone, 27% and 30%
of cells underwent apoptosis, respectively. In Sharp-1 overexpress-
ing cells however, apoptosis was signiﬁcantly reduced to 16% and
18%, respectively (Fig. 3C and D). Similar effects were seen with
cisplatin treatment (Supplementary Fig. 1). Consistent with the
above results, Sharp-1 overexpressing cells exhibited a signiﬁcant
decrease in caspase-3 activity in response to 5-FU compared to
control cells (Fig. 3E). Moreover, compared to control cells,
Sharp-1 overexpressing cells showed a striking reduction of the
mitotic marker phospho-histone H3 (Fig. 3F), conﬁrming that the
cells are arrested in the G2 phase.
3.3. Sharp-1 attenuates the p53 response to DNA damage
Activation of the p53 pathway is essential for the response to
DNA damage. To study the mechanisms underlying apoptosis-
resistance conferred by Sharp-1, we analyzed p53 expression lev-
els and its transcriptional activity. NIH3T3 cells were pre-treated
with doxycycline for 16 h to induce Sharp-1 expression. Cells
were then co-treated with 5-FU for 0, 3, 8 and 24 h. Sharp-1
was expressed for the duration of drug treatment (Fig. 4A). In
control cells, p53 was signiﬁcantly up-regulated as early as 3 h
(Fig. 4B). In contrast, the p53 response was attenuated three
and 8 h after 5-FU treatment in Sharp-1 expressing cells, although
at late stages there was no obvious difference. Concomitantly the
expression of p21waf1/cip1 and Bax was reduced suggesting that
p53 transcriptional activity is attenuated by Sharp-1 expression.
In contrast, Bcl2 levels were increased in Sharp-1 overexpressing
cells.
To further examine p53 activity, we analyzed the mRNA levels
of several p53 target genes (Fig. 4C). Consistent with reduced
apoptosis and p53 levels, the expression of Puma, Noxa, Bax,
Fig. 2. Sharp-1 induces GADD45a and Brca1 expression. (A) Cells were left untreated () or treated with doxycycline (+Doxy) for 16 and 36 h. Sharp-1, cyclin B1,
phosphorylated cdc2 (Tyr 15), CDK2, p21waf/cip1 and p53 were analyzed by Western blot. (B) GADD45a and Brca1 mRNA was analyzed by quantitative RT-PCR. GAPDH was
used as an internal control. (C) The level of the mitotic marker H3 (ser 10) was determined before after doxycycline treatment by Western blot. (D) Expression of RPA, 53BP1,
and MDC1 was analyzed by RT-PCR. The results are representative of two independent experiments. (E) PCNA and GAPDH levels were analyzed by Western blot.
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in Sharp-1 overexpressing cells. In contrast, GADD45a was ele-
vated compared to control cells at early time points and not in-
duced further. It is noteworthy that Sharp-1 expression alone is
sufﬁcient to down regulate Bax and Stra13 expression even in
the absence of 5-FU, and upregulate GADD45a levels (Figs. 2
and 4; time 0, +doxycycline). On the other hand, the reduced
expression of Puma and Noxa may be due to reduced p53 activityas the expression of these genes is not altered by Sharp-1 alone.
We have previously reported that Stra13 is repressed by Sharp-1,
and regulates DNA-damage-induced apoptosis [9,15]. Consistent
with these studies Stra13 is down-regulated in Sharp-1 express-
ing cells that are resistant to apoptosis. Similar to the responses
seen with 5-FU, Sharp-1 overexpressing cells also showed re-
duced levels of p53, p21 and Bax in response to cisplatin (data
not shown).
Fig. 3. Sharp-1 is up-regulated by DNA-damaging stimuli and inhibits apoptosis. (A) NIH3T3 cells were treated with 30 lM 5-FU for 0, 3, 8, 12 and 24 h. Sharp-1 and
GADD45a expression was analyzed by RT-PCR. 36B4 was used as an internal control (left panel). Sharp-1 mRNA was examined in cells cultured for various time points by RT-
PCR (right panel). (B) NIH3T3 cells were treated with 2 lM etoposide or 20 lM cisplatin for 0, 24 and 48 h or 0, 8 and 16 h, respectively. Sharp-1 and GADD45a expression
was analyzed by RT-PCR. (C) NIH3T3 cells were pre-treated with doxycycline for 8 h to induce Sharp-1, and were then co-treated with 12.5 lM or 25 lM 5-FU for 72 h.
Representative histograms of cell cycle proﬁles without and with Sharp-1 overexpression are shown. (D) The percentage of sub-G1 fraction in cells treated with 5-FU in the
absence and presence of Sharp-1 overexpression was determined. Sharp-1 overexpression resulted in a signiﬁcant decrease (*P < 0.05) in the percentage of apoptotic cells.
Error bars indicate mean ± S.E. (E) Caspase-3 activity was determined in control and Sharp-1 expressing cells under conditions described in (C). Sharp-1 expressing cells
exhibited a signiﬁcant (*P < 0.05) decrease in caspase-3 activity compared to controls. (F) Control and doxycycline induced cells (16 h) were treated with 5-FU and phospho
H3 (ser10) levels was determined.
J.-J. Liu et al. / FEBS Letters 584 (2010) 619–624 623Taken together, our studies indicate a novel regulatory axis
through which Sharp-1 regulates survival of normal cells via acti-
vation of cell cycle checkpoints. This function provides protectionfrom the cytotoxic effects of DNA damaging agents. This survival
mechanism is applicable to normal cells (this study). It is conceiv-
able that inappropriate Sharp-1 expression plays a role tumorigen-
Fig. 4. Sharp-1 inhibits expression of pro-apoptotic p53 targets. (A and B) Cells
were left untreated () or induced with doxycycline (+) for 16 h prior to addition of
15 lM 5-FU for 0, 3, 8 and 24 h. Sharp-1, p53, p21, Bax, and Bcl2 were analyzed by
Western blot. (C) The expression of Noxa, Puma, Bax, Stra13 and GADD45a was
analyzed by RT-PCR in control and doxycycline induced cells after various time
points of 5-FU treatment as indicated.
624 J.-J. Liu et al. / FEBS Letters 584 (2010) 619–624esis and/or tumor progression and other disorders such as prema-
ture ageing arising from cell survival subsequent to DNA damage.
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